CVS Caremark Corporation Revenue Growth: 13.56%
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
None selected
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
CVS Revenue Growth Rankings
| Overall | 62nd percentile | 1669 of 4427 |
| Sector | 66th percentile | 287 of 867 in Services |
| Industry | 62nd percentile | 3 of 8 in Drug Stores |
CVS Revenue Growth Range, Past 5 Years
| Minimum | -57.25% | Sep 1995 |
| Maximum | 170.01% | Mar 1997 |
| Average | 14.49% |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
You may also be interested in these CVS related companies
CVS News
Cooperman's Omega Advisors Buys Beaten Up Names Like Transocean (RIG) and RIM (RIMM) (RIG), Sells GM (GM)
Feb 10, 12:18PM Street Insider
Feb 10, 12:18PM Street Insider
UBS Maintains a 'Buy' on CVS Caremark (CVS); Raising FY12/13 EPS Estimates
Feb 09, 2:36PM Street Insider
Feb 09, 2:36PM Street Insider
I guess $WAG's pain is $CVS's gain. Will be interesting to see how sticky their new biz is if Walgreens ever figures out the $ESRX deal.
about 2 days ago by bradloncar
about 2 days ago by bradloncar
CVS Caremark's CEO Discusses Q4 2011 Results - Earnings Call Transcript
Feb 08, 2:40PM Seeking Alpha
Feb 08, 2:40PM Seeking Alpha
CVS (CVS) Posts 16% Rise in Q4 Profit as Pharmacy Services Segment Outperforms
Feb 08, 8:24AM Street Insider
Feb 08, 8:24AM Street Insider
Listen to $CVS Q4 2011 earnings call (EPS 0.89 vs est 0.89) - live at 08:30 AM, ondemand after - http://stks.co/2Ikd
about 3 days ago by earningscast
about 3 days ago by earningscast
CVS Caremark (CVS) Reports In-Line Q4 EPS; Boosts Q112 EPS, Guides FY12 EPS
Feb 08, 6:47AM Street Insider
Feb 08, 6:47AM Street Insider
Watch list + In Play For Feb 8: http://stks.co/2ISg $DIS $CVS $CTSH $TWX $CNQ $APC $TSO $ANF $$
about 4 days ago by TheArmoTrader
about 4 days ago by TheArmoTrader
$wag vs $cvs--just based on my personal experiences--really prefer cvs
about 4 days ago by eddyhooks
about 4 days ago by eddyhooks
Q4 Preview: CVS (CVS) Quarter Should Be Telegraphed But Investors Will Want Details
Feb 07, 4:36PM Street Insider
Feb 07, 4:36PM Street Insider
CVS Caremark Charitable Trust "Surprises" Non-Profits With $4.3 Million in Funding
Feb 07, 1:25PM PR Newswire
Feb 07, 1:25PM PR Newswire
Is Medco-Express Scripts deal dead? $MHS & $ESRX tanked yesterday but both up a bit pre-market today. Keep eye on them as well as $CVS $WAG.
about 4 days ago by lamonicabuzz
about 4 days ago by lamonicabuzz
63 $SPY Holdings Have A NR7 Day. Number has been low recently worth noting. $CVS $AMD $HOG charts pullbacks in uptrends http://stks.co/2BCC
about 11 days ago by tradewithpete
about 11 days ago by tradewithpete
$CVS agrees to pay $5M to settle Medicare drug false advertising claims
about 24 days ago by MoodTrader
about 24 days ago by MoodTrader
Stocks trading ex-dividend one week from today: http://stks.co/1tnr $APA $BCR $CODI $CVS $HRL $LTC
about 30 days ago by DynamicDividend
about 30 days ago by DynamicDividend
Baby Buffetteer Todd Combs Cruuuuuuushing It So Far | via @ReformedBroker http://stks.co/1sw2 $V $BRK-B $MA $GD $DTV $INTC $CVS
about 31 days ago by STNet
about 31 days ago by STNet
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CVS | 43.18 | 0.18 | 0.42% | 56.20B |
| BMY | 31.90 | -0.09 | -0.28% | 54.06B |
| MSFT | 30.50 | -0.28 | -0.89% | 256.53B |
| WMT | 61.90 | -0.06 | -0.10% | 213.35B |
| BAC | 8.07 | -0.11 | -1.34% | 81.78B |
| AMTD | 17.01 | 0.00 | 0.00% | 9.34B |
| EBAY | 33.02 | -0.23 | -0.71% | 42.63B |
| ALU | 2.19 | 0.25 | 12.89% | 4.96B |
| INTC | 26.70 | -0.17 | -0.61% | 135.93B |
| AAPL | 493.42 | 0.25 | 0.05% | 458.59B |
